OTC · Drug Manufacturers - Specialty & Generic

Isracann Biosciences Inc. (ISCNF) Stock

$0.00 OTC: ISCNF Healthcare

Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure.

Valuation

MetricValue
Price$0.00
Market Cap$1760
P/E Ratio-0.47
P/B Ratio0.01
P/S Ratio0.00
EPS (TTM)$-0.02
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-252.75%
ROA-34.99%
ROCE-0.08%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.30

Annual Financials (USD)

Metric20182019202020212022
Revenue$1.0M$0$0$0$0
Operating Profit$-6.0M$-6.0M$-11.0M$-5.0M$-2.0M
Net Profit$-7.0M$-10.0M$-24.0M$-25.0M$-5.0M
EPS$-0.33$-0.75$-0.26$-0.18$-0.03
Op Margin-535.5%————

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$15.0M$16.0M$28.0M$4.0M$4.0M
Total Liabilities$1.0M$1.0M$2.0M$0$4.0M
Cash$8.0M$4.0M$4.0M$2.0M$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-3.0M$-3.0M$-10.0M$-4.0M$-2.0M
Investing Cash Flow$-12.0M$-1.0M$-3.0M$0$0
Financing Cash Flow$3.0M$10.0M$13.0M$2.0M$0
Net Cash Flow$8.0M$-4.0M$0$-2.0M$-2.0M
Free Cash Flow$-9.0M$-3.0M$-11.0M$-4.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.97
FCF Yield-66.46%
Quick Ratio0.38
Interest Coverage-0.17
Return 1Y0.00%
Return 3Y-99.96%
Return 5Y-99.99%

Ownership

Insiders Held0.17%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
KLCM Advisors, Inc.12,0002025-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVCNFAvicanna Inc. $0.10 +4.32% -4.25 $12.15M 0.00%
CAAOFINDVR Brands Inc. $0.00 — 0.00 $3025 0.00%
CHOOFChoom Holdings Inc. $0.00 — 0.00 $4670 0.00%
CWBHFCharlotte's Web Holdings, Inc. $0.25 +4.12% -1.08 $39.86M 0.00%
EVRRFMolecule Holdings Inc. $0.00 — -0.11 $626130 0.00%

About Isracann Biosciences Inc.

Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure. Additionally, it ships its products internationally to Germany. The company rebranded to Isracann Biosciences Inc. in October 2019, having previously been known as Atlas Blockchain Group Inc. Founded in 2010, its corporate headquarters are situated in Vancouver, Canada.

Isracann Biosciences Inc. (ISCNF) stock trades at $0.00 with a market capitalization of $1760. The stock is valued at a price-to-earnings (P/E) ratio of -0.47, price-to-book of 0.01, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Isracann Biosciences Inc. generates a return on equity (ROE) of -252.75%, return on capital employed of -0.08%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.isracann.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides